Wire · opportunities
AstraZeneca taps Oracle to help improve recruitment for clinical trials
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 20 October 2026 · Fusion42 review
AstraZeneca has entered a non-binding partnership with Oracle to explore AI-driven solutions aimed at improving patient recruitment and clinical trial efficiency across several disease areas. The partnership leverages AI and data capabilities to identify eligible patients earlier and enhance clinical trial success rates.
This Wire brief sits within Fusion42's coverage of Health, and 5 sources have reported it.
◆ ◆ The Wire takeaway
You can no longer overlook AI tools to speed patient recruitment in drug development. AstraZeneca's move shows startups improving trial enrolment now gain a clearer route to partnerships with Big Pharma and cloud giants like Oracle.
◆ Coverage
5 sources · 20 Oct 2026
◆ Related on Wire
◆ Topics